Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma

Neuroradiology

Volumn 46, Issue 8, 2004, Pages 642-648

  Kremer, S ^a,b   Grand, S ^b   Remy C ^b   Pasquier, B ^b   Benabid, A L ^b   Bracard, S ^a   Le Bas, J F ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Brain; Meningiomas; Metastases; MR perfusion imaging

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ARTICLE; BRAIN BLOOD VOLUME; BRAIN METASTASIS; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; DURA MATER; HUMAN; IMAGE ANALYSIS; LUNG CARCINOMA; LYMPHOMA; MENINGIOMA; MERKEL CELL TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECTUM CARCINOMA; WHITE MATTER;

EID: 4444293174     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-004-1194-2     Document Type: Article

References (24)

1. Simionescu M. Metastatic tumors of the brain: a follow-up study of 195 patients with neurosurgical considerations. J Neurosurg 1960; 17:361-373.
2. Johnson MD, Powell S, Boyer P, Weil R, Moots P. Dural lesions mimicking meningiomas. Hum Pathol 2002; 33:1211-1226.
3. Khalfallah M, Roche P, Figarrela-Branger D, Malca S, Pellet W. Isolated dural metastasis mimicking meningioma. A case report. Neurochirurgie 1999; 45:250-254.
4. Rumana C, Hess K, Shi W, Sawaya R. Metastatic brain tumors with dural extension. J Neurosurg 1998; 89: 552-558.
5. Tagle P, Villanueva P, Torrealba G, Huete I. Intracranial metastasis or meningioma ? An uncommon clinical diagnostic dilemma. Surg Neurol 2002; 58:241-245.
6. Cha S, Knopp E, Johnson G, Wetzel S, Litt A, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002; 223:11-29.
7. Griebel J, Mayr N, De Vries, Knopp MV, Gneiting T, Kremser C, et al. Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging. J Magn Reson Imaging 1997; 7:111-119.
8. Pathak AP, Schmainda K, Ward B, Linderman J, Rebro K, Greene A. MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis. Magn Reson Med 2001; 46:735-747.
9. Barbier E, Lamalle L, Decorps M. Methodology of brain perfusion imaging. J Magn Reson Imaging 2001; 13:496-520.
10. Provenzale JM, Wang GR, Brenner T, Petrella JR, Sorensen AG. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002; 178:711-716.
11. Hartmann M, Heiland S, Harting I, Tronnier VM, Sommer C, Ludwig R, et al. Distinguishing of primary cerebral lymphoma from high grade glioma with perfusion weighted magnetic resonance imaging. Neuroscience Lett 2003; 338:119-122.
12. Kremer S, Grand S, Remy C, Esteve F, Lefournier V, Pasquier B, et al. Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol 2002; 29:105-113.
13. Maeda M, Itoh S, Kimura H, Iwasaki T, Hayashi N, Yamamoto K, et al. Vascularity of meningiomas and neurinomas: assessment with dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 1994; 163:181-186.
14. Kleihues P, Cavenee W, eds. Pathology and genetics of tumours of the nervous system, 2nd edn. Lyon: International Agency for Research, 2000.
15. Rosen B, Belliveau J, Vevea J, Brady T. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14:249-265.
16. Sheporaitis L, Osborn A, Smirniotopoulos J, Clunie D, Howieson J, D'agostino A. Radiologic-pathologic correlation: intracranial meningioma. Am J Neuroradiol 1992; 13:29-37.
17. Buetow M, Buetow P, Smimiotopoulos J. Typical, atypical, and misleading features in meningioma. Radiographics 1991; 11:1087-1106.
18. Goldsher D, Litt A, Pinto R, Bannon K, Kricheff I. Dural "tail" associated with meningiomas on Gd-DTPA-enhanced MR images: characteristics, differential diagnostic value, and possible implications for treatment. Radiology 1990; 176:447-450.
19. Nakau H, Miyazawa T, Tamai S, Tsuchiya K, Shima K, Shirotani T, et al. Pathologic significance of meningeal enhancement ("flare sign") of meningiomas on MRI. Surg Neurol 1997; 48:584-591.
20. Tokumaru A, O'uchi T, Eguchi T, Kawamoto S, Kokubo T, Suzuki M, et al.. Prominent meningeal enhancement adjacent to meningioma on Gd-DTPA-enhanced MR images: histopathologic correlation. Radiology 1990; 175:431-433.
21. Wilms G, Lammens M, Marchal G, Calenbergh FV, Plets C, Van Frayenhoven L, et al.. Thickening of dura surrounding meningiomas: MR features. J Comput Assist Tomogr 1989; 13:763-768.
22. Quint D, McGillicuddy J. Meningeal metastasis of the cerebellopontine angle demonstrating "dural tail" sign. Can Assoc Radiol J 1994; 45:40-43.
23. Wilms G, Lammens M, Marchal G, Demaerel P, Verplancke J, Van Calenbergh F, et al. Prominent dural enhancement adjacent to nonmeningiomatous malignant lesions on contrast-enhanced MR images. AJNR Am J Neuroradiol 1991; 12:761-764.
24. Kremer S, Grand S, Berger F, Hoffmann D, Pasquier B, Remy C, et al. Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases. Neuroradiology 2003; 45:44-49.